Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Genet.

Sec. Computational Genomics

Volume 16 - 2025 | doi: 10.3389/fgene.2025.1669007

This article is part of the Research TopicMolecular Underpinnings of Genetic and Rare Diseases: From Diagnostic Tools to Therapeutic ApproachesView all 5 articles

Genetic and in silico functional characterization of a novel structural variant in the PAH gene by long-read sequencing and structural modelling

Provisionally accepted
  • 1Universidad de Chile Instituto de Nutricion y Tecnologia de los Alimentos, Macul, Chile
  • 2Universidad de Santiago de Chile Departamento de Biologia, Santiago, Chile
  • 3University of Chile, Santiago, Chile

The final, formatted version of the article will be published soon.

Abstract Introduction: Phenylketonuria (PKU) is an inherited metabolic disorder caused by biallelic variants in the PAH gene, leading to phenylalanine accumulation and progressive neuronal damage. Over 3,000 variants have been described worldwide; however, a previously unreported exon duplication was identified in Chile, whose genetic and functional characteristics remained unknown. Methods: A patient carrying a duplication of exon 2 in the PAH gene, previously detected by MLPA, was analyzed using nanopore sequencing coupled with CRISPR/Cas9 enrichment (nCATS) to determine the location, size, and orientation of the variant. Specific fragment amplification by PCR and Sanger sequencing was subsequently performed on samples from this patient and seven additional individuals to confirm the presence of the structural variant. Structural modelling of the resulting PAH protein was also conducted to predict functional consequences. Results: The nCATS technique identified a ~18 kb tandem duplication between exons 1 and 3 of the PAH gene. This exon duplication was confirmed by PCR and Sanger sequencing in all eight patients. Additionally, an adenine insertion was detected at the junction site of the duplication. Structural modelling predicted an additional N-terminal segment that would likely interfere with sensing of phenylalanine. Discussion: The clinical, genetic and in silico functional characterization of this variant, using nCATS and structural modeling, suggests a mild, but relevant alteration in PAH enzymatic function. These findings support the delineation of genotype-phenotype correlations for complex structural variants, which may contribute to the development of personalized therapeutic strategies, while enriching both national and international PKU variant databases.

Keywords: Phenylketonuria (PKU), PAH gene, CRISPR/Cas9, Oxford Nanopore Sequencing (ONT), exon duplication, protein modeling

Received: 25 Jul 2025; Accepted: 08 Sep 2025.

Copyright: © 2025 Gallardo, Gaete, Maldonado, Morales, Peña, Hamilton, Faundes and Santa Maria. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Victor Faundes, University of Chile, Santiago, Chile
Lorena Santa Maria, Universidad de Chile Instituto de Nutricion y Tecnologia de los Alimentos, Macul, Chile

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.